Jakob is also Senior Fellow at the School of Oriental and African Studies, University of London, where he teaches a Green Finance course. He holds a PhD in Finance from the Conservatoire National des Arts et Metiers. Jakob is Special Research Fellow to the Japanese Financial Services Agency, and previously served as Academic Advisor to the Bank of England and EIOPA. The Inspire Sleep Apnea Innovation is the only internal neurostimulation treatment for obstructive sleep apnea currently approved by the Food and Drug Administration. His work has also informed the climate stress-test scenario design of major central banks and financial supervisors. As part of the programme, Jakob authored the first COVID-19 stress-test scenarios, informing the regulatory response of supervisors in Europe and the United States to the crisis. In 2020, Jakob launched the 1in1000 research programme designed to integrate complex and long-term risks into financial supervision and decision-making. Over 1,000 organizations have used PACTA to conduct portfolio tests to date. PACTA remains the most widely used alignment methodology in the world, endorsed by a number of governments and financial supervisors to track financial sector alignment. Jakob led the development of the first methodology in the world to measure the alignment of financial portfolios with climate goals (PACTA). He co-founded the 2° Investing Initiative network in New York and Berlin and serves as Executive Director of 2° Investing Initiative Deutschland. Jakob Thomae is one of the leading global experts on sustainable finance and long-term risks.
0 kommentar(er)
